Literature DB >> 15627854

Animal-assisted therapy ameliorates anhedonia in schizophrenia patients. A controlled pilot study.

Inbar Nathans-Barel1, Pablo Feldman, Barry Berger, Ilan Modai, Henry Silver.   

Abstract

BACKGROUND: Anhedonia, a component of the negative symptom dimension and a core phenomenon in schizophrenia, is associated with poor social functioning and is resistant to treatment. We tested the hypothesis that animal-assisted therapy (AAT) may improve anhedonia.
OBJECTIVE: To compare the effect of psychosocial treatment sessions in which a dog was an active participant (AAT) with comparable sessions without a dog, using a controlled protocol.
METHOD: The hedonic tone of 10 chronic schizophrenia patients who participated in 10 weekly interactive sessions of AAT was compared to a control group treated without animal assistance. The hedonic tone was measured with the Snaith-Hamilton Pleasure Scale. Subjective quality of life variables and clinical symptoms were also assessed.
RESULTS: The AAT group showed a significant improvement in the hedonic tone compared to controls. They also showed an improvement in the use of leisure time and a trend towards improvement in motivation.
CONCLUSION: AAT may contribute to the psychosocial rehabilitation and quality of life of chronic schizophrenia patients. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15627854     DOI: 10.1159/000082024

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  10 in total

Review 1.  Anhedonia in schizophrenia.

Authors:  Daniel H Wolf
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

2.  Dog-assisted therapies and activities in rehabilitation of children with cerebral palsy and physical and mental disabilities.

Authors:  Dilek Tunçay Elmacı; Sibel Cevizci
Journal:  Int J Environ Res Public Health       Date:  2015-05-12       Impact factor: 3.390

Review 3.  Patient benefit of dog-assisted interventions in health care: a systematic review.

Authors:  Martina Lundqvist; Per Carlsson; Rune Sjödahl; Elvar Theodorsson; Lars-Åke Levin
Journal:  BMC Complement Altern Med       Date:  2017-07-10       Impact factor: 3.659

Review 4.  Dog alerting and/or responding to epileptic seizures: A scoping review.

Authors:  Amélie Catala; Hugo Cousillas; Martine Hausberger; Marine Grandgeorge
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

5.  Incorporating animal-assisted therapy in mental health treatments for adolescents: A systematic review of canine assisted psychotherapy.

Authors:  Melanie G Jones; Simon M Rice; Susan M Cotton
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

6.  Paws for Thought: A Controlled Study Investigating the Benefits of Interacting with a House-Trained Dog on University Students Mood and Anxiety.

Authors:  Emily L R Thelwell
Journal:  Animals (Basel)       Date:  2019-10-21       Impact factor: 2.752

7.  Psychosocial and psychophysiological effects of human-animal interactions: the possible role of oxytocin.

Authors:  Andrea Beetz; Kerstin Uvnäs-Moberg; Henri Julius; Kurt Kotrschal
Journal:  Front Psychol       Date:  2012-07-09

8.  Animal Assisted Therapy (AAT) Program As a Useful Adjunct to Conventional Psychosocial Rehabilitation for Patients with Schizophrenia: Results of a Small-scale Randomized Controlled Trial.

Authors:  Paula Calvo; Joan R Fortuny; Sergio Guzmán; Cristina Macías; Jonathan Bowen; María L García; Olivia Orejas; Ferran Molins; Asta Tvarijonaviciute; José J Cerón; Antoni Bulbena; Jaume Fatjó
Journal:  Front Psychol       Date:  2016-05-06

Review 9.  Could Animal-Assisted Therapy Help to Reduce Coercive Treatment in Psychiatry?

Authors:  Sonja Widmayer; Stefan Borgwardt; Undine E Lang; Christian G Huber
Journal:  Front Psychiatry       Date:  2019-11-14       Impact factor: 4.157

10.  Exposure to household pet cats and dogs in childhood and risk of subsequent diagnosis of schizophrenia or bipolar disorder.

Authors:  Robert Yolken; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Kevin Sweeney; Amalia Squire; Faith Dickerson
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.